JODIE VAUGHN: Open Payments
NPI 1073065140 · GIBSON CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 12 payments from 7 companies in 2025. Trend: 2023 $51 · 2024 $161 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Lilly USA, LLC | 3 | $45 |
| Novo Nordisk Inc | 1 | $25 |
| Radius Health, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, AIRSUPRA, MOUNJARO, Ozempic, Tymlos, ZEPBOUND, CAPLYTA, REPATHA.
Industry payments across IL — which companies pay providers there.
